Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, Silvia; Quint, Wim; Alemany, Laia; Geraets, Daan; Ellen Klaustermeier, Jo; Lloveras, Belen; Tous, Sara; Felix, Ana; Eduardo Bravo, Luis; Shin, Hai-Rim; Vallejos, Carlos; Alonso de Ruiz, Patricia; Lima, Marcus; Guimera, Nuria; Clavero, Omar; Alejo, Maria; Llombart-Bosch, Antonio; Cheng-Yang, Chou; Alejandro Tatti, Silvio; Kasamatsu, Elena; Iljazovic, Ermina; Odida, Michael; Prado, Rodrigo; Seoud, Muhieddine; Grce, Magdalena; USUBÜTÜN, ALP; Jain, Asha; Hernandez Suarez, Gustavo; Estuardo Lombardi, Luis; Banjo, Aekunbiola; Menendez, Clara; Javier Domingo, Efren; Velasco, Julio; Nessa, Ashrafun; Chichareon, Saibua; Qiao, You; Lerma, Enrique; Garland, Suzanne; Sasagawa, Toshiyuki; Ferrera, Annabelle; Hammouda, Doudja; Mariani, Luciano; Pelayo, Adela; Steiner, Ivo; Oliva, Esther; Meijer, Chris; Al-Jassar, Waleed; Cruz, Eugenia; Wright, Thomas; Puras, Ana; Ladines Llave, Cecilia; Tzardi, Maria; Agorastos, Theodoros; Garcia-Barriola, Victoria; Clavel, Christine; Ordi, Jaume; Andujar, Miguel; Castellsague, Xavier; Sanchez, Gloria; Nowakowski, Andrzej; Bornstein, Jacob; Munoz, Nubia; Xavier Bosch, F.

doi:10.1016/s1470-2045(10)70230-8

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Atıf İçin Kopyala

de Sanjose S., Quint W. G. V., Alemany L., Geraets D. T., Ellen Klaustermeier J., Lloveras B., ...Daha Fazla

LANCET ONCOLOGY, cilt.11, sa.11, ss.1048-1056, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 11 Sayı: 11
Basım Tarihi: 2010
Doi Numarası: 10.1016/s1470-2045(10)70230-8
Dergi Adı: LANCET ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1048-1056
Hacettepe Üniversitesi Adresli: Evet

Özet

Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer.